title: [Action of prodigiozan on the embryonic development of experimental animals].
abstract: Administration of prodigiozan was found to cause in embryos of albino rats and golden hamsters depending on the dose and pregnancy term hemolytic anemia, thrombohemorrhagic syndrome and a decrease of the body weight.
authors.forename: Iu I
authors.initials: IuI
authors.lastname: Bandazhevskiĭ
authors.forename: A V
authors.initials: AV
authors.lastname: Miron
authors.forename: L E
authors.initials: LE
authors.lastname: Vinogradova
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001835:Body Weight / Q000187:drug effects; D006224:Cricetinae; D004305:Dose-Response Relationship, Drug; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D005260:Female; D005865:Gestational Age; D008647:Mesocricetus; D011135:Polysaccharides, Bacterial / Q000633:toxicity*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011354:Prodigiozan / Q000633:toxicity*; D051381:Rats
chemical_list: D011135:Polysaccharides, Bacterial; D011354:Prodigiozan
vernacular_title: Deĭstvie prodigiozana na razvitie zarodysheĭ éksperimental'nykh zhivotnykh.